Incyte Corp
INCY- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000879169
In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 10 sales; 861 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Incyte Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 553
- 0 vs. Q4 2022
- Shares held
- 218.0M
- +7.46M (+3.5%) vs. Q4 2022
- Total value
- $15.8B
- −$1.10B (−6.5%) vs. Q4 2022
- New holders
- 70
- 247 more added
- Sold out
- 70
- 159 more reduced
6 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 861 | $23.0B |
| Q1 2026 | 815 | $19.2B |
| Q4 2025 | 822 | $19.9B |
| Q3 2025 | 713 | $16.8B |
| Q2 2025 | 658 | $13.4B |
| Q1 2025 | 628 | $11.5B |
| Q4 2024 | 650 | $12.6B |
| Q3 2024 | 594 | $12.0B |
| Q2 2024 | 585 | $12.0B |
| Q1 2024 | 587 | $12.4B |
| Q4 2023 | 558 | $13.7B |
| Q3 2023 | 530 | $12.4B |
| Q2 2023 | 528 | $13.1B |
| Q1 2023 | 553 | $15.8B |
| Q4 2022 | 559 | $16.9B |
| Q3 2022 | 537 | $14.2B |
| Q2 2022 | 538 | $16.0B |
| Q1 2022 | 532 | $16.4B |
| Q4 2021 | 526 | $14.9B |
| Q3 2021 | 496 | $14.0B |
| Q2 2021 | 524 | $17.2B |
| Q1 2021 | 493 | $16.5B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Incyte Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Twin Focus Capital Partners, LLC | 0 | $0 | 0.00% | −2,534−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −2,516−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −2,514−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −2,506−100.0% | Sold out |
| Alta Wealth Advisors LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −2,134−100.0% | Sold out |
| Anfield Capital Management, LLC | 0 | $0 | 0.00% | −734−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −426−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −395−100.0% | Sold out |
| General Partner, Inc. | 0 | $0 | 0.00% | −316−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Seldon Capital LP | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| DT Investment Partners, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| WFA of San Diego, LLC | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Sierra Capital LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Addison Advisors LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| My Personal CFO, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Alaska Permanent Fund Corp | – | – | – | – | Not filed |
| Seeyond | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Allstate Investment Management Co | – | – | – | – | Not filed |
| Neo Ivy Capital Management | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |